Characteristics and prognosis of skin cancer arising from burn scars: a systematic review
DOI:
https://doi.org/10.2340/jphs.v61.45793Keywords:
Marjolin’s ulcer, burn-scar carcinoma, squamous cell carcinoma, basal cell carcinomaAbstract
Background: Burn scars are recognized risk factors for malignant skin transformation, most notably Marjolin’s ulcer (MU). Despite extensive documentation in case reports and series, the epidemiological characteristics and prognosis of burn scar-related skin cancers have lacked large-scale systematic synthesis.
Methods: We conducted a systematic review in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, registered with PROSPERO (CRD42024545404), covering literature from PubMed, Scopus, and Web of Science up to 18 January 2024. Eligible studies included case reports, case series, and observational studies reporting any type of skin cancer in burn scars. Data were extracted on demographics, burn and tumor characteristics, treatment, latency, outcomes, and risk of bias using Joanna Briggs Institute tools.
Results: A total of 211 studies reporting 830 cases were included. The mean latency period from burn injury to cancer diagnosis was 21.7 years (SD = 19.6). Males constituted 53% of patients, with third-degree burns predominating (89.37%) and lower limbs being the most affected site (33.59%). Squamous cell carcinoma (SCC) was the most frequent malignancy (67.19%), followed by basal cell carcinoma (BCC, 3.83%) and other cancers (15.33%). Recurrence occurred in 13.2% of cases; mortality was 6.96%. SCC accounted for most deaths (63.8%), while melanoma and sarcoma exhibited high rates of recurrence and mortality. Lymph node metastasis and distant metastasis were found in 7.56 and 4.74% of cases, respectively.
Conclusion: Skin cancers arising from burn scars, especially SCC, demonstrate aggressive clinical behavior with significant morbidity and mortality. Reduced latency periods and high metastatic potential highlight the importance of vigilant, long-term surveillance and radical initial treatment. This review provides a contemporary benchmark for epidemiological understanding and supports calls for international registries, molecular diagnostics, and standardized management protocols for burn scar malignancies.
Downloads
References
Lee HB, Han SE, Chang LS, et al. Malignant melanoma on a thermal burn scar. Arch Craniofac Surg. 2019;20(1):58–61.
https://doi.org/10.7181/acfs.2018.02103 DOI: https://doi.org/10.7181/acfs.2018.02103
Xiao H, Deng K, Liu R, et al. A review of 31 cases of Marjolin’s ulcer on scalp: is it necessary to preventively remove the scar? Int Wound J. 2019;16(2):479–485.
https://doi.org/10.1111/iwj.13058 DOI: https://doi.org/10.1111/iwj.13058
Fleming MD, Hunt JL, Purdue GF, et al. Marjolin’s ulcer: a review and reevaluation of a difficult problem. J Burn Care Rehabil. 1990;11(5):460–469.
https://doi.org/10.1097/00004630-199009000-00016 DOI: https://doi.org/10.1097/00004630-199009000-00016
Xiang F, Song H-P, Huang Y-S. Clinical features and treatment of 140 cases of Marjolin’s ulcer at a major burn center in southwest China. Exp Ther Med. 2019;17(5):3403–3410.
https://doi.org/10.3892/etm.2019.7364 DOI: https://doi.org/10.3892/etm.2019.7364
Onesti MG, Fino P, Fioramonti P, et al. Ten years of experience in chronic ulcers and malignant transformation. Int Wound J. 2015;12(4):447–450.
https://doi.org/10.1111/iwj.12134 DOI: https://doi.org/10.1111/iwj.12134
Bazaliński D, Przybek-Mita J, Barańska B, et al. Marjolin’s ulcer in chronic wounds – review of available literature. Contemp Oncol (Pozn). 2017;21(3):197–202.
https://doi.org/10.5114/wo.2017.70109 DOI: https://doi.org/10.5114/wo.2017.70109
Mitra S, Panda S, Sikka K, et al. Multimodality management of locoregionally extensive Marjolin ulcer: a case report and review of the literature. Wounds. 2024;36(5):166–169.
https://doi.org/10.25270/wnds/23138 DOI: https://doi.org/10.25270/wnds/23138
Harland DL, Robinson WA, Franklin WA. Deletion of the
p53 gene in a patient with aggressive burn scar carcinoma. J Trauma. 1997;42(1):104–107.
https://doi.org/10.1097/00005373-199701000-00018 DOI: https://doi.org/10.1097/00005373-199701000-00018
Hayashi M, Tamura G, Kato N, et al. Genetic analysis of cutaneous squamous cell carcinomas arising from different areas. Pathol Int. 2003;53(9):602–607.
https://doi.org/10.1046/j.1440-1827.2003.01523.x DOI: https://doi.org/10.1046/j.1440-1827.2003.01523.x
Lee SH, Shin MS, Kim HS, et al. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol. 2000;114(1):122–126.
https://doi.org/10.1046/j.1523-1747.2000.00819.x DOI: https://doi.org/10.1046/j.1523-1747.2000.00819.x
Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis. Burns. 2005;31(4):403–413.
https://doi.org/10.1016/j.burns.2005.02.015 DOI: https://doi.org/10.1016/j.burns.2005.02.015
Copcu E. Marjolin’s ulcer: a preventable complication of burns? Plast Reconstr Surg. 2009;124(1):156e–164e.
https://doi.org/10.1097/PRS.0b013e3181a8082e DOI: https://doi.org/10.1097/PRS.0b013e3181a8082e
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
https://doi.org/10.1136/bmj.n71 DOI: https://doi.org/10.1136/bmj.n71
Barker TH, Stone JC, Sears K, et al. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023;21(3):478–493.
https://doi.org/10.11124/JBIES-22-00125 DOI: https://doi.org/10.11124/JBIES-22-00125
Gasparoto TH, de Oliveira CE, de Freitas LT, et al. Inflammatory events during murine squamous cell carcinoma development. J Inflamm (Lond). 2012;9(1):46.
https://doi.org/10.1186/1476-9255-9-46 DOI: https://doi.org/10.1186/1476-9255-9-46
Barati M, Akhondi M, Mousavi NS, et al. Pluripotent stem cells: cancer study, therapy, and vaccination. Stem Cell Rev and Rep. 2021;17(6):1975–1992.
https://doi.org/10.1007/s12015-021-10199-7 DOI: https://doi.org/10.1007/s12015-021-10199-7
Kim KE, Cho D, Park HJ. Air pollution and skin diseases: adverse effects of airborne particulate matter on various skin diseases. Life Sci. 2016;152:126–134.
https://doi.org/10.1016/j.lfs.2016.03.039 DOI: https://doi.org/10.1016/j.lfs.2016.03.039
Cendrowicz E, Sas Z, Bremer E, et al. The role of macrophages in cancer development and therapy. Cancers (Basel). 2021;13(8):1946.
https://doi.org/10.3390/cancers13081946 DOI: https://doi.org/10.3390/cancers13081946
Stratigos AJ, Garbe C, Dessinioti C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: diagnostics and prevention-update 2023. Eur J Cancer. 2023;193:113251.
https://doi.org/10.1016/j.ejca.2023.113251 DOI: https://doi.org/10.1016/j.ejca.2023.113251
Squamous cell skin cancer – Guidelines detail [Internet]. [cited 2025 Jun 27]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1465
Keshri VR, Abimbola S, Parveen S, et al. Navigating health systems for burn care: patient journeys and delays in Uttar Pradesh, India. Burns. 2023;49(7):1745–1755.
https://doi.org/10.1016/j.burns.2023.03.009 DOI: https://doi.org/10.1016/j.burns.2023.03.009
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from 2024 all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
